Replies to post #125380 on Biotech Values

[biomaven0]

I think the FDA has now given a route-map to approval, and so subsequent entrants will have an easier time of it than MNTA did. The Amphastar disclosures added to my conviction on this.

I just don't find any of the evidence to the contrary pointed to on this board that convincing.

Peter